Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...

Podrobná bibliografie
Hlavní autoři:	Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere
Médium:	Článek
Jazyk:	English
Vydáno:	Taylor & Francis Group 2017-04-01
Edice:	Expert Review of Vaccines
Témata:	rabivax-s rabies purified vero cell rabies vaccine safety immunogenicity
On-line přístup:	http://dx.doi.org/10.1080/14760584.2017.1294068

Podobné jednotky

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
Autor: Piyada Angsuwatcharakon, a další
Vydáno: (2018-02-01)

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
Autor: Jia Li, a další
Vydáno: (2024-12-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
Autor: D.J. Briggs, a další

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
Autor: Jing Wang, a další
Vydáno: (2017-01-01)

DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
Autor: A. L. Kravtsov, a další
Vydáno: (2019-08-01)

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens
Autor: Hua-Kun Lv, a další
Vydáno: (2025-02-01)

Study on immune persistence of the CTN-1V strain rabies vaccine in humans
Autor: Lidong Wang, a další
Vydáno: (2024-03-01)

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis
Autor: Scott Preiss, a další
Vydáno: (2018-06-01)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
Autor: Nianmin Shi, a další
Vydáno: (2017-06-01)

Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination
Autor: Zheng-Gang Zhu, a další
Vydáno: (2018-11-01)

Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine
Autor: Jia Li, a další
Vydáno: (2024-12-01)

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context
Autor: Gagandeep Kang, a další
Vydáno: (2023-07-01)

Infection and Prevention of Rabies Viruses
Autor: Shiu-Jau Chen, a další
Vydáno: (2025-02-01)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
Autor: Pornthep Chanthavanich, a další
Vydáno: (2018-04-01)

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures
Autor: Xiaohong Wu, a další
Vydáno: (2023-08-01)

Development of mRNA rabies vaccines
Autor: Zixin Fang, a další
Vydáno: (2024-12-01)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
Autor: Thomas Moulenat, a další
Vydáno: (2020-03-01)

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China
Autor: Zhenzhen Liang, a další
Vydáno: (2024-11-01)

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
Autor: Lei Zhang, a další
Vydáno: (2021-08-01)

A STUDY OF THE ULTRASTRUCTURE OF THE SURFACE OF THE TRANSPLANTABLE LINE VERO CELLS INFECTED WITH THE RABIES VIRUS (RABV, LISSAVIRUS, RHABDOVIRIDAE)
Autor: S. V. Generalov, a další
Vydáno: (2017-10-01)

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
Autor: Xingyu Zhou, a další
Vydáno: (2019-04-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
Autor: Heng Shen, a další
Vydáno: (2021-02-01)

Rabies and rabies immunobiological preparations: vaccinations Pasteur to the contemporary biotechnology
Autor: E. G. Abramova, a další
Vydáno: (2019-11-01)

Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran
Autor: Pooneh Rahimi, a další
Vydáno: (2014-08-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
Autor: Xiaoyuan Huang, a další
Vydáno: (2023-01-01)

Management of rabies
Autor: J. Weyer, a další
Vydáno: (2019-07-01)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
Autor: Irina Matveeva, a další
Vydáno: (2022-09-01)

The Formation of the Eastern Africa Rabies Network: A Sub-Regional Approach to Rabies Elimination
Autor: Emily G Pieracci, a další
Vydáno: (2017-07-01)

Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings
Autor: Sunil Karande, a další
Vydáno: (2015-07-01)

A case of human rabies in the Urban Area of Ribeirão Preto, SP, Brazil
Autor: SILVA Jorgete M., a další
Vydáno: (1997-01-01)

Factors related to vaccines for both patients exposed with rabies and dogs
Autor: Lam Quy Ngo, a další
Vydáno: (2022-03-01)

Factors related to vaccines for both patients exposed with rabies and dogs
Autor: Lam Quy Ngo, a další
Vydáno: (2022-03-01)

MANAJEMEN INFEKSI RABIES BERISIKO TINGGI: STUDI KASUS TANPA SERUM ANTI-RABIES
Autor: Mahdika Ambarwaty, a další
Vydáno: (2023-12-01)

Amino Acid Mutation in Position 349 of Glycoprotein Affect the Pathogenicity of Rabies Virus
Autor: Jun Luo, a další
Vydáno: (2020-04-01)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
Autor: Gadey Sampath, a další
Vydáno: (2017-07-01)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
Autor: Anurag Agarwal, a další
Vydáno: (2022-11-01)

Rabies virus monitoring in bat populations in Rondônia state, Brazil
Autor: Marilene Fernandes de Almeida, a další

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
Autor: Weerawan Hattasingh, a další
Vydáno: (2022-01-01)

Analysis of determination of rabies virus neutralizing antibody titres in the sera of vaccinated humans
Autor: A. Yu. Butirskiy, a další
Vydáno: (2019-12-01)

Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis
Autor: Shi-Yuan Wang, a další
Vydáno: (2022-01-01)